(Source: Business Wire)

PicksThatMove.com opines promising trading opportunities with likely
potential for gain. The companies we follow have favorable revenue
models for business development at upward cycles. Please visit us at PicksThatMove.com
to view more of our profiled stocks.
Morning movers in biopharmaceutical sector include:
GenovaBiotherapeutics Inc. (OTCBB:GVBP) up 84% closing at $0.80, Tenet
Healthcare Corp (NYSE:THC) down 0.17% trading at $5.75, Discovery
Laboratories Inc. (NASDAQ:DSCO) down 5% trading at $1.01, ARIAD
Pharmaceuticals Inc. (NASDAQ: ARIA) down 7% trading at $2.54 and KERX
Biopharmaceuticals Inc. (NASDAQ:KERX) up 1.30% trading at $1.55.
Our intention is bringing knowledge to beginners who wish to learn more
about stock trading.
Small-cap, penny stock biopharmaceutical companies have attributed to
massive payoffs when stock prices surge on news.
There are identifiable variables driving profit in the biopharmaceutical
sector, for example: news of mergers & acquisitions; anticipated
research and positive clinical data results; pending applications
granted FDA clearance and approval; and government support.
The most recent Ernst
& Young annual biotechnology report shows that mergers &
acquisitions were worth $28.5 billion over the last year in the US
alone. The less obvious benefit of these massive biotech deals forecast
a strengthening of credit markets as bankers are willing to endorse them.
Positive clinical data is another major influence on stock appreciation,
auguring high end double digit percentage gains almost immediately for
penny stocks; while FDA clearance and approval exponentially increases
the value of a stock as a gatekeeper to market entry internationally.
Government support and healthcare initiatives are also major drivers in
the sector. At the National Academy of Sciences President Barack Obama
announced the government should spend more than 3% of its GDP scientific
R&D. The US has earmarked a $3.5 trillion budget for fiscal 2010
requiring the development of generic, cost effective biotech drugs that
will create competition in the market as well as proposals to inhibit
Big Drugs, and brand name companies from using anti-competitive
agreements to keep inexpensive small cap comers off the market.
Sign up for our FREE alerts at Picksthatmove.com
About Picksthatmove.com
Picksthatmove.com
is a leading stock website that provides free daily alerts on stocks
that are moving up. Picksthatmove.com also tracks small cap stocks that
are on the brink of exploding. We also feature companies on our website
with research report, analysis, and newsletters. To feature a company on
our web site please contact us at editorial@picksthatmove.com.
Picksthatmove.com is an independent electronic publication that provides
information on selected publicly traded companies. Picksthatmove.com is
not a registered investment advisor or broker-dealer. Picksthatmove.com's
affiliates, officers, directors and employees may buy and sell
additional shares in any company mentioned herein and may profit in the
event those shares rise in value. Please do your own Due Diligence
before investing in any of the stocks mentioned above.
Nick Hunter, RIA, of Picksthatmove.com is a member of the
National Association of Securities Dealers, CRD number 2022366
A service of YellowBrix, Inc.